Clinical trial
Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation
NCT00224770 · Daniel Hanley, Other · Completed
Key facts
| NCT number | NCT00224770 |
|---|---|
| Title | Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation |
| Official title | Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation |
| Acronym | MISTIE |
| Lead sponsor | Daniel Hanley, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH Genentech, Inc. Industry Emissary International LLC |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Intracerebral Hemorrhage |
| Intervention type | Drug, Procedure |
| Interventions | MIS+Cathflo Activase (drug), Intraoperative stereotactic CT-Guided Endoscopic Surgery |
| Enrollment | 141 |
| Start date | Aug 1, 2005 |
| Primary completion | Aug 1, 2012 |
| Completion | Apr 1, 2013 |
| First posted | Sep 23, 2005 |
| Last update posted | Jun 18, 2015 |
| Countries | Canada, Germany, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: